TABLE OF CONTENTS
Volume 22, Issue 47 (20 October 2003)
Reviews
Guest Editor FREE
Gary D Kruh
Oncogene 22: 7261; doi:10.1038/sj.onc.1206931
Introduction to resistance to anticancer agents FREE
Gary D Kruh
Oncogene 22: 7262-7264; doi:10.1038/sj.onc.1206932
Cisplatin: mode of cytotoxic action and molecular basis of resistance FREE
Zahid H Siddik
Oncogene 22: 7265-7279; doi:10.1038/sj.onc.1206933
Mechanisms of Taxol resistance related to microtubules FREE
George A Orr, Pascal Verdier-Pinard, Hayley McDaid and Susan Band Horwitz
Oncogene 22: 7280-7295; doi:10.1038/sj.onc.1206934
Mechanisms of resistance to topoisomerase I-targeting drugs FREE
Zeshaan A Rasheed and Eric H Rubin
Oncogene 22: 7296-7304; doi:10.1038/sj.onc.1206935
Retinoids in cancer therapy and chemoprevention: promise meets resistance FREE
Sarah J Freemantle, Michael J Spinella and Ethan Dmitrovsky
Oncogene 22: 7305-7315; doi:10.1038/sj.onc.1206936
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling FREE
Robert Clarke, Minetta C Liu, Kerrie B Bouker, Zhiping Gu, Richard Y Lee, Yuelin Zhu, Todd C Skaar, Bianca Gomez, Kerry O'Brien, Yue Wang and Leena A Hilakivi-Clarke
Oncogene 22: 7316-7339; doi:10.1038/sj.onc.1206937
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) FREE
L Austin Doyle and Douglas D Ross
Oncogene 22: 7340-7358; doi:10.1038/sj.onc.1206938
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance FREE
Mitchell R Smith
Oncogene 22: 7359-7368; doi:10.1038/sj.onc.1206939
The role of glutathione-S-transferase in anti-cancer drug resistance FREE
Danyelle M Townsend and Kenneth D Tew
Oncogene 22: 7369-7375; doi:10.1038/sj.onc.1206940
A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage FREE
Mark Meyers, Arlene Hwang, Mark W Wagner, Andrew J Bruening, Martina L Veigl, W David Sedwick and David A Boothman
Oncogene 22: 7376-7388; doi:10.1038/sj.onc.1206941
Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias FREE
Neil P Shah and Charles L Sawyers
Oncogene 22: 7389-7395; doi:10.1038/sj.onc.1206942
Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death FREE
Lori A Hazlehurst, Terry H Landowski and William S Dalton
Oncogene 22: 7396-7402; doi:10.1038/sj.onc.1206943
Drug methylation in cancer therapy: lessons from the TPMT polymorphism FREE
Eugene Krynetski and William E Evans
Oncogene 22: 7403-7413; doi:10.1038/sj.onc.1206944
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance FREE
Scott H Kaufmann and David L Vaux
Oncogene 22: 7414-7430; doi:10.1038/sj.onc.1206945
Resistance to antifolates FREE
Rongbao Zhao and I David Goldman
Oncogene 22: 7431-7457; doi:10.1038/sj.onc.1206946
Vaults: a ribonucleoprotein particle involved in drug resistance? FREE
Marieke H Mossink, Arend van Zon, Rik J Scheper, Pieter Sonneveld and Erik AC Wiemer
Oncogene 22: 7458-7467; doi:10.1038/sj.onc.1206947
P-glycoprotein: from genomics to mechanism FREE
Suresh V Ambudkar, Chava Kimchi-Sarfaty, Zuben E Sauna and Michael M Gottesman
Oncogene 22: 7468-7485; doi:10.1038/sj.onc.1206948
The role of p53 in chemosensitivity and radiosensitivity FREE
Wafik S El-Deiry
Oncogene 22: 7486-7495; doi:10.1038/sj.onc.1206949
Transcriptional regulation of ABC drug transporters FREE
Kathleen W Scotto
Oncogene 22: 7496-7511; doi:10.1038/sj.onc.1206950
Strategies for reversing drug resistance FREE
Tito Fojo and Susan Bates
Oncogene 22: 7512-7523; doi:10.1038/sj.onc.1206951
Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy FREE
Vijaya L Damaraju, Sambasivarao Damaraju, James D Young, Stephen A Baldwin, John Mackey, Michael B Sawyer and Carol E Cass
Oncogene 22: 7524-7536; doi:10.1038/sj.onc.1206952
